You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 15 December 2025

Sec. Renal Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1734058

Correction: Mitochondrial iron overload-mediated inhibition of Nrf2-HO-1/GPX4 assisted ALI-induced nephrotoxicity

  • 1. Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, China

  • 2. Tianjin University of Traditional Chinese Medicine, Tianjin, China

  • 3. School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China

Article metrics

View details

620

Views

40

Downloads

There was a mistake in Figure 2 as published. The image for the DFO group in Figure 2C was mistakenly replaced with the control group’s image, resulting in partial overlap between Figure 1C and Figure 2C. Additionally, to prevent misinterpretation of the ALI (25 μM) groups in Figures 1C and Figure 2C, we have used new images for the ALI group in Figure 2C. Finally, the housekeeping protein β-actin in Figure 2E was inadvertently duplicated from Figure 5C, and we have corrected this error. The corrected Figure 2 appears below.

FIGURE 2

Bar graphs, fluorescence images, and Western blot results illustrating effects of different treatments: A) Cell viability comparison among control, DFO, ALI, and DFO+ALI groups. B) Fe2+ concentration levels. C) Fluorescence microscopy images for control, DFO, ALI, and DFO+ALI groups. D) GSH-MBB fluorescence intensity histogram. E) Western blot showing 4-HNE expression against β-actin. F) Bar graph of 4-HNE/β-actin ratio across groups. Statistical significance is indicated with asterisks and hashes.

ALI-induced cytotoxicity could be alleviated by iron chelator DFO. (A) Cell viability of HK-2 cells was detected using CCK-8 assay. (B) Intracellular Fe2+ levels in HK-2 cells treated by ALI and DFO. (C,D) Intracellular GSH content in HK-2 (X200). (E,F) The protein levels of 4-HNE were measured by Western blot. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. the control group; #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 vs. the ALI group.

The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

aristolactam I, nephrotoxicity, ferroptosis, mitochondrial iron overload, Nrf2-HO-1/GPX4

Citation

Deng H-F, Yue L-X, Wang N-N, Zhou Y-Q, Zhou W, Liu X, Ni Y-H, Huang C-S, Qiu L-Z, Liu H, Tan H-L, Tang X-L, Wang Y-G, Ma Z-C and Gao Y (2025) Correction: Mitochondrial iron overload-mediated inhibition of Nrf2-HO-1/GPX4 assisted ALI-induced nephrotoxicity. Front. Pharmacol. 16:1734058. doi: 10.3389/fphar.2025.1734058

Received

28 October 2025

Accepted

28 November 2025

Published

15 December 2025

Volume

16 - 2025

Edited and reviewed by

Ying-Yong Zhao, Northwest University, China

Updates

Copyright

*Correspondence: Yue Gao,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics